IL33 and hepatocellular carcinoma: A notable investigation through immunohistochemistry and enzyme‐linked immunosorbent assays revealed elevated IL‐33 levels in both the serum and liver tissues of HCC patients, compared to healthy controls and adjacent non‐tumoral liver tissues.13